Tmunity

Tmunity Therapeutics Inc. is a private biotherapeutics company dedicated to delivering the full potential of next-generation T-cell immunotherapies to more patients suffering from devastating diseases, thereby saving and improving lives. Through extensive collaboration with the University of Pennsylvania (UPenn), combined with groundbreaking scientific, clinical, and manufacturing expertise, as well as the proven track record of its founders, Tmunity is developing personalized immunotherapies for cancer that are rapidly advancing toward clinical applications. Headquartered in Philadelphia, Tmunity leverages UPenn’s laboratories and production facilities, along with a dedicated cGMP manufacturing facility in Norristown, Pennsylvania, for process optimization and production expansion to support the clinical development of T-cell therapies.